Investigators reviewed ocular side effects of semaglutide use from a global population-based study across 180 countries.

Disease-associated vision changes are common in GCA, with no significant difference in visual improvement observed with IV glucocorticoids vs oral therapy.

ORLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective ...

Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness ...

Dompé earns FDA Commissioner’s Priority Voucher to fast-track its NGF therapy for NAION, accelerating review of a potential ...

THE Public Health Agency (PHA) is highlighting the importance of looking after your eyes through all stages of life, ...

The Public Health Agency (PHA) is highlighting the importance of looking after your eyes through all stages of life, ...

Oculis Holding AG (Nasdaq: OCS / XICE: OCS) ('Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical ...

ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic ...